Photo of { Kasiani C. Myers, MD}

Kasiani C. Myers, MD


  • Member, Division of Bone Marrow Transplantation and Immune Deficiency
  • Professor, UC Department of Pediatrics

About

Biography

I always wanted to be a physician, and specifically a pediatrician. My father is an adult subspecialist, but I was drawn to the care of medically complex children. Now, I enjoy being the bridge between basic research and the clinic.

In my clinical practice, I specialize in treating patients with bone marrow failure and hematopoietic stem cell transplant for non-malignant diseases, with a special emphasis on Shwachman Diamond syndrome and dyskeratosis congenita. My research interests focus on translational and clinical studies in leukemogenesis and bone marrow failure related to these two conditions. I also study the complications of stem cell transplants, including bronchiolitis obliterans and fertility preservation.

I decided to pursue my research interests after my experience as a resident physician and fellow at Cincinnati Children’s. I enjoyed getting to know my patients on the bone marrow transplant and hematology/oncology units. Plus, I was mentored by two of the world’s foremost experts in the field, Dr. Stella Davies and Dr. Richard Harris, right here at Cincinnati Children’s.

After I completed my postdoctoral training, I joined the faculty of the Division of Bone Marrow Transplantation and Immune Deficiency at Cincinnati Children’s within the UC Department of Pediatrics. Now, in addition to clinical work and research, I serve as the co-director of the North American Shwachman Diamond Syndrome Registry.

BS: University of Michigan, Ann Arbor, MI, 2000,

MD: Case Western Reserve University, Cleveland, OH, 2004,

Post-Doctoral: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2010,

Certifications: Pediatrics, 2007

Additional Languages

French, Greek

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Toward Standardized Screening for Chronic GVHD: Insights from the Engraft Learning Network. Alkhouli, L; Badia, P; Bakinowski, E; Craddock, J; Culbertson, C; Dandoy, CE; Davies, SM; Desalvo, AM; Gorfinkel, L; Huber, J; Patel, V; Jodele, S; Wall, S; Epling, P. Transplantation and Cellular Therapy. 2026; 32(2):s252-s253.

Relationship between Social Drivers of Health and Clinician Adherence to Late Effects Screening Among Allogeneic HCT Survivors in the United States. Taylor, AO; Hong, S; Jones, S; Ng, K; Gooley, TA; Bhatt, N; Hellewell, EM; Sung, AD; Ahmed, N; Morey, C; Yingling, S; Edgar, CM; Browning, AL; Lee, CJ. Transplantation and Cellular Therapy. 2026; 32(2):s24-s25.

Radiation-Free Reduced-Intensity Conditioning Achieves Excellent Outcomes in Pediatric Severe Aplastic Anemia. Koo, J; Miller, E; O'conner, A; Myers, KC; Mehta, PA; Davies, SM. Transplantation and Cellular Therapy. 2026; 32(2):s581.

Pediatric Pulmonary Rehabilitation after Hematopoietic Stem Cell Transplantation. Paisley, A; Foster, K; Gover, I; Diebold, S; Lane, A; Hardie, W; Ruff, K; Burg, G; Towe, C; Khandelwal, P; Koo, J; Davies, SM; Myers, K. Transplantation and Cellular Therapy. 2026; 32(2):s63.

MCP-1 in Broncho-Alveolar Fluid and Plasma in Children with Lung Injury after Hematopoietic Stem Cell Transplant: A Transpire Study. Strecker, L; Abts, MF; Baker, KS; Freedman, JL; Doherty, EE; Eissa, H; Gaffin, JM; Goldfarb, SB; Houin, P; Josephson, MB; Young, LR; Zinter, MS; Davies, SM; Ibrahimova, A. Transplantation and Cellular Therapy. 2026; 32(2):s581-s582.

Lower Isn't Better: Baseline LDL-C Identifies Endothelial Vulnerability and Outcomes after HSCT. Koo, J; Langenberg, L; Walter, E; Zhao, X; Setchell, K; Lake, KE; Khandelwal, P; Lane, A; Manjrekar, P; Myers, KC; Reynaud, D; Sabulski, A; Teusink-Cross, A; Jodele, S; Davies, SM. Transplantation and Cellular Therapy. 2026; 32(2):s594.

Longitudinal Outcomes of Reproductive Function in Male Pediatric Hematopoietic Stem Cell Transplant Survivors. Lawhorn, E; Mani, B; Howell, JC; Davies, SM; Myers, K; Hudda, Z. Transplantation and Cellular Therapy. 2026; 32(2):s356.

Liver Disease in Shwachman Diamond Syndrome: Implications for Hematopoietic Stem Cell Transplantation. Koo, J; Schwarz, D; Haney, M; Putra, J; Kim, J; Cheng, L; Korn, E; Steltz, SK; Schwarz, L; Loveless, SK; Myers, KC; Shimamura, A; Grover, AS; Wehrman, A. Transplantation and Cellular Therapy. 2026; 32(2):s328-s329.

Got Nutrition? Exclusion of Nutrition Intervention at Key Points during Hematopoietic Stem Cell Transplantation Negatively Impacts Frailty. Bota, KE; Young, K; Wall, J; Koo, J; Myers, K; Ramos, KN; Dandoy, CE; Davies, SM; Taggart, CB. Transplantation and Cellular Therapy. 2026; 32(2):s607-s608.

Activating Epic’s Flowsheet for Standardized Chronic GVHD Assessment: A Multi-Center Implementation Framework to Enable Standardized Documentation. Maier, ST; Dandoy, CE; Davies, SM; Gorfinkel, L; Huber, J; Jodele, S; Kapadia, M; Kent, G; Lehmann, LE; Myers, K; Nguyen, A; Nishitani, M; Parker, L; Epling, P. Transplantation and Cellular Therapy. 2026; 32(2):s520-s521.

From the Blog

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Loading ...
Loading ...